drugset

drugset / Trial / NCT02787876

Pegteograstim in Children With Solid Tumors

NCT02787876 ↗

Phase 2 Unknown 34 enrolled Samsung Medical Center Green Cross Corporation · collab

NaSingle-groupOpen-labelTreatment

Summary

To evaluate the efficacy and safety of pegteograstim on chemotherapy-induced neutropenia in children with solid tumors

Timeline

Start: 2016-10-04
Primary completion: 2018-10
Completion: 2018-11

Publications

Cho HW, Lee JW, Ju HY, Hyun JK, Yoo KH, Koo HH, Kim K, Sung KW. Safety and Efficacy of Pegteograstim on Chemotherapy-induced Neutropenia in Children and Adolescents With Solid Tumors. J Pediatr Hematol Oncol. 2022 Mar 1;44(2):e362-e367. doi: 10.1097/MPH.0000000000002206.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Pegteograstim	Protein / enzyme biologic	100 ug/kg	—

Indications